SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001595585-18-000008
Filing Date
2018-08-10
Accepted
2018-08-09 21:17:13
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a20180630q210qdocument.htm 10-Q 1173976
2 EXHIBIT 31.1 exhibit311ceo302certificat.htm EX-31.1 11423
3 EXHIBIT 31.2 exhibit312cfo302certificat.htm EX-31.2 11431
4 EXHIBIT 32.1 exhibit321ceoandcfo906cert.htm EX-32.1 6796
  Complete submission text file 0001595585-18-000008.txt   4889118

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tcda-20180630.xml EX-101.INS 922119
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20180630.xsd EX-101.SCH 30851
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20180630_cal.xml EX-101.CAL 51978
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20180630_def.xml EX-101.DEF 183276
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20180630_lab.xml EX-101.LAB 449996
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20180630_pre.xml EX-101.PRE 278683
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38558 | Film No.: 181006863
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1